Pulmonary Disease, Chronic Obstructive: Clinical Trials

5,395 trials for Pulmonary Disease, Chronic Obstructive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3375 completed, 815 unknown, 417 recruiting, 292 terminated. 2046 Not applicable, 559 Phase 2, 556 Phase 3, 439 Phase 4, 354 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2046Completed 1165, Unknown 357, Recruiting 197, Terminated 105, Not yet recruiting 102, Active not recruiting 53, Withdrawn 47, Enrolling by invitation 13, Suspended 7
Phase 2559Completed 391, Terminated 57, Unknown 35, Recruiting 34, Withdrawn 16, Not yet recruiting 12, Active not recruiting 10, Suspended 3, Enrolling by invitation 1
Phase 3556Completed 426, Unknown 41, Terminated 30, Recruiting 25, Withdrawn 19, Not yet recruiting 11, Active not recruiting 2, Enrolling by invitation 2
Phase 4439Completed 298, Unknown 62, Terminated 26, Withdrawn 26, Recruiting 14, Not yet recruiting 9, Active not recruiting 4
Phase 1354Completed 275, Terminated 21, Recruiting 18, Unknown 18, Withdrawn 9, Not yet recruiting 6, Active not recruiting 4, Suspended 3
Early Phase 134Completed 17, Unknown 9, Terminated 5, Active not recruiting 1, Not yet recruiting 1, Recruiting 1

Follow Pulmonary Disease, Chronic Obstructive: new trials by email Literature Review of Pulmonary Disease, Chronic Obstructive trials Research Report on Pulmonary Disease, Chronic Obstructive

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Developing an Intervention to Optimize Virtual Care Adoption for COPD Management
VC-OPTIONS - Chronic Obstructive Pulmonary Disease
Not applicableNot yet recruitingVA Office of Research and Development402027-09-022026-09-29
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
Remote Management, Remote Monitoring Only - COPD (Chronic Obstructive Pulmonary Disease), Acute Exacerbation of COPD
Not applicableNot yet recruitingSir Run Run Shaw Hospital2362027-08-012026-08-06
RSV Vaccination to Reduce Recurrent AECOPD
RSV vaccination (Arexvy, GlaxoSmithKline) - COPD, RSV
Phase 4Not yet recruitingChinese University of Hong Kong3202027-07-012026-04-13
cfMSC Stem Cell Therapy Targeting COPD
clonal fetal MSCs - Chronic Obstructive Pulmonary Disease (COPD)
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-08-27
Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype
Roflumilast Oral Tablet, Azithromycin 250 mg - Chronic Obstructive Pulmonary Disease With Exacerbation
Phase 4Not yet recruitingSidra Aziz702027-02-012026-08-31
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg, Comparator - Trimbow® - Chronic Obstructive Pulmonary Disease
Phase 3Not yet recruitingEurofarma Laboratorios S.A.12522027-01-302026-10-26
Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Metered cryospray (MCS) - COPD (Chronic Obstructive Pulmonary Disease), Chronic Bronchitis
Not applicableNot yet recruitingCSA Medical, Inc.102027-01-022026-10-05
Pulmonary Rehabilitation Frequency in COPD Patients
Pulmonary Rehabilitation - COPD, COPD (Chronic Obstructive Pulmonary Disease)
Not applicableNot yet recruitingHospital Universitario Fundación Alcorcón1582027-01-012026-05-08
A Study of the Effect of a Nurse Navigator Program on High Risk Patients
Nurse Navigator Program - Patient Readmission, Arthroplasty, Replacement, Knee
Not applicableNot yet recruitingMayo Clinic3002027-01-012026-03-19
The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD
Inhaled Nitric Oxide, Placebo - Chronic Obstructive Pulmonary Disease
Phase 1 / Phase 2Not yet recruitingUniversity of Alberta802026-12-012026-07-08
Effect of add-on Doxofylline on Lung Function in Stable COPD
Doxofylline - Chronic Obstructive Pulmonary Disease
Phase 4Not yet recruitingUniversity of Milan782026-12-012026-04-29
Portable Positive Pressure Therapy Device
BREATHE, BiPAP, COPD Inhaler - COPD
Not applicableNot yet recruitingKoronis Biomedical Technologies202026-12-012025-03-25
A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease
TQC3927 inhalation aerosol, Glyceryl bromide/formoterol inhalation aerosol - Chronic Obstructive Pulmonary Disease
Phase 2SuspendedChia Tai Tianqing Pharmaceutical Group Co., Ltd.902026-12-012026-09-03
Effect on Bronchodilation Response and Ventilation Heterogeneity of Different Inhalation Volumes in COPD
Inhalation of bronchodilation therapy at FRC, Inhalation of bronchodilation therapy at RV - COPD, Lung Injury
Not yet recruitingUniversity of Milan302026-12-012026-05-04
Effectiveness and Efficiency of Home Telemonitoring and Non-invasive Ventilation in Patients With COPD and Hypercapnia (EVALECO)
Home Non-Invasive Ventilation and Telemonitoring - Pulmonary Disease, Chronic Obstructive (COPD), Hypercapnia
Not yet recruitingAir Liquide Healthcare Spain922026-12-012026-10-28
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
Enrolling by invitationNational Institute of Allergy and Infectious Diseases (NIAID)3502026-11-022026-10-28
Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease
1MSTS - COPD (Chronic Obstructive Pulmonary Disease), Asthma (Diagnosis)
Not yet recruitingJacob Sandberg1202026-11-012026-09-23
Effect of Dietary Fiber Supplementation on Systemic Inflammation and Clinical Parameters in COPD
Dietary Fiber Supplementation, Placebo Control - Pulmonary Disease, Chronic Obstructive (COPD), Pulmonary Diseases
Not applicableNot yet recruitingJúnea Regina Pires Drews1002026-11-012026-10-14
Urolithin A Supplementation During Pulmonary Rehabilitation in Patients With COPD
Urolithin A, Placebo - Chronic Obstructive Pulmonary Disease (COPD)
Phase 2Not yet recruitingBryan A. Ross1982026-11-012026-10-13
Acute Muscular and Vascular Responses to a Single Session of Exercise With BFR in COPD
Blood Flow Restriction, Standard exercise session - Control Condition, Pulmonary Disease (COPD), Chronic Obstructive
Not applicableNot yet recruitingUniversity Hospital, Grenoble402026-11-012026-06-30

Showing 20 of 5395. Sign in to see all of them.

Narrower conditions

Asthma (437)  ·  Emphysema (299)  ·  Dyspnea (233)  ·  Motor Activity (226)  ·  Bronchitis, Chronic (201)  ·  Heart Failure (201)  ·  Lung Diseases (195)  ·  Lung Diseases, Obstructive (104)  ·  Diabetes Mellitus (100)  ·  Lung Diseases, Interstitial (89)  ·  Respiratory Insufficiency (85)  ·  Lung Neoplasms (81)  ·  Anxiety Disorders (70)  ·  Pneumonia (70)

Broader conditions

Disease Attributes (5395)  ·  Pathological Conditions, Signs and Symptoms (5395)  ·  Pathologic Processes (5388)  ·  Chronic Disease (5358)  ·  Respiratory Tract Diseases (5347)  ·  Lung Diseases, Obstructive (5291)  ·  Lung Diseases (5200)  ·  Bronchial Diseases (701)  ·  Immune System Diseases (498)  ·  Signs and Symptoms (483)  ·  Respiration Disorders (473)  ·  Behavior (459)  ·  Hypersensitivity (448)  ·  Respiratory Hypersensitivity (446)  ·  Hypersensitivity, Immediate (439)

Interventions

Tiotropium Bromide (242)  ·  Formoterol Fumarate (135)  ·  Salmeterol Xinafoate (99)  ·  Glycopyrrolate (81)  ·  Albuterol (77)  ·  indacaterol (73)  ·  Exercise (72)  ·  Fluticasone (71)  ·  Budesonide (64)  ·  olodaterol (55)  ·  Fluticasone-Salmeterol Drug Combination (48)  ·  Noninvasive Ventilation (47)  ·  Ipratropium (46)  ·  GSK573719 (41)  ·  Roflumilast (40)

Sponsors

GlaxoSmithKline (275)  ·  AstraZeneca (236)  ·  Boehringer Ingelheim (235)  ·  Novartis Pharmaceuticals (88)  ·  Chiesi Farmaceutici S.p.A. (61)  ·  Riphah International University (61)  ·  Imperial College London (49)  ·  University of Zurich (38)  ·  Pearl Therapeutics, Inc. (37)  ·  VA Office of Research and Development (36)  ·  Assiut University (35)  ·  Schön Klinik Berchtesgadener Land (35)  ·  Laval University (33)  ·  Brigham and Women's Hospital (28)  ·  National Heart, Lung, and Blood Institute (NHLBI) (28)

Countries

United States (1273)  ·  United Kingdom (607)  ·  Germany (536)  ·  Canada (399)  ·  France (399)  ·  China (376)  ·  Spain (303)  ·  Italy (274)  ·  Netherlands (267)  ·  Turkey (Türkiye) (249)  ·  Denmark (240)  ·  Belgium (202)  ·  Poland (176)  ·  Taiwan (156)  ·  South Korea (151)

Top investigators

Esther Garcia, MD (18)  ·  Konrad E Bloch, MD (14)  ·  Talant M Sooronbaev, MD (13)  ·  Colin Reisner, MD (11)  ·  Dave Singh, MD (11)  ·  Ronald G Crystal, MD (11)

Results publications

PMID 33511633, PMID 34495549, PMID 32943047, PMID 35815359, PMID 37542951, PMID 42149813, PMID 42551404, PMID 17507545, PMID 35514131, PMID 39423760, PMID 12091180, PMID 19720809, PMID 24127811, PMID 33124005, PMID 10377201, PMID 1759018, PMID 17951621, PMID 20102307, PMID 23497334, PMID 24314123, PMID 25066329, PMID 25359355, PMID 25496316, PMID 25918120, PMID 28419462, PMID 30077810, PMID 32462607, PMID 32671684, PMID 32848381, PMID 33152467, PMID 38616018, PMID 42476723, PMID 11282762, PMID 15764761, PMID 16055882, PMID 16310554, PMID 16565429, PMID 16936234, PMID 17197484, PMID 18786894, PMID 19179484, PMID 19729666, PMID 20071991, PMID 20427767, PMID 20843247, PMID 21103404, PMID 21227674, PMID 21397482, PMID 22206353, PMID 22793945

NIH funding

2017 (25), 2009 (23), 2015 (22), 2018 (16), 2023 (16), 2008 (15), 2025 (15), 2014 (14), 2019 (13), 2016 (9), R01HL082480 (5), U10HL074424 (5), 2005 (3), R01HL136682 (3), P50CA090440 (2)